Effect of the p38 kinase inhibitor, SB203580, in a model of airway inflammation

被引：0
|
作者：
Birrell, M [1 ]
Haddad, EB [1 ]
McCluskie, K [1 ]
Hele, D [1 ]
Phipps, S [1 ]
Webber, SE [1 ]
Foster, M [1 ]
Belvisi, MG [1 ]
机构：
[1] Rhone Poulenc Rorer Res & Dev, Dagenham Res Ctr, Dept Pharmacol, Dagenham RM10 7XS, Essex, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
89P
引用
收藏
页码：U46 / U46
页数：1
相关论文
共 50 条
  • [21] The p38 MAP kinase inhibitor, SB203580, antagonizes the inhibitory effect of IL-1 beta on longterm potentiation in the rat dentate gyrus in vitro
    Coogan, A
    ONeill, LAJ
    OConnor, JJ
    JOURNAL OF PHYSIOLOGY-LONDON, 1997, 501P : P86 - P87
  • [22] Neuroprotective effects of SB203580 (p38 MAP kinase inhibitor) against Endothelin-1-induced retinal ganglion cell death
    Krishnamoorthy, Vignesh
    He, Shaoqing
    Chaphalkar, Renuka
    Kodati, Bindu
    Krishnamoorthy, Raghu R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [23] The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus
    Jin, Na
    Wang, Qi
    Zhang, Xing
    Jiang, Donghai
    Cheng, Hao
    Zhu, Kejian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (09) : 1319 - 1326
  • [24] SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus
    Saleshando, G
    O'Connor, JJ
    NEUROSCIENCE LETTERS, 2000, 288 (02) : 119 - 122
  • [25] Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580
    Koranteng, RD
    Swindle, EJ
    Davis, BJ
    Dearman, RJ
    Kimber, I
    Flanagan, BF
    Coleman, JW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (01): : 81 - 87
  • [26] Gene Expression Analysis to Evaluate the Effect of p38 Specific Inhibitor SB203580 on SEB-Induced Apoptosis Related Pathways
    Sondgeroth, Casey
    Hesse, Lisa
    Allbaugh, Alyssa
    Mendis, Chanaka
    Jett, Marti
    FASEB JOURNAL, 2013, 27
  • [27] Interactions between SB202190 and SB203580 with the CCK1 receptor and CCK analogues with P38 MAP kinase
    Morel, C
    Ibarz, G
    Oiry, C
    Gagne, D
    Galleyrand, JC
    Martinez, J
    REGULATORY PEPTIDES, 2004, 122 (01) : 32 - 32
  • [28] The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
    Shi, Qinghai
    Cheng, Liping
    Liu, Zhengxiang
    Hu, Keyan
    Ran, Jihua
    Ge, Di
    Fu, Jianfeng
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (03) : 276 - 282
  • [29] p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
    Nuttikarn Nokkaew
    Podsawee Mongkolpathumrat
    Ruttanapong Junsiri
    Supawit Jindaluang
    Nichagron Tualamun
    Niya Manphatthanakan
    Nareumon Saleesee
    Marisa Intasang
    Jantira Sanit
    Punyanuch Adulyaritthikul
    Kantapich Kongpol
    Sarawut Kumphune
    Nitirut Nernpermpisooth
    Indian Journal of Clinical Biochemistry, 2021, 36 : 228 - 234
  • [30] p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
    Nokkaew, Nuttikarn
    Mongkolpathumrat, Podsawee
    Junsiri, Ruttanapong
    Jindaluang, Supawit
    Tualamun, Nichagron
    Manphatthanakan, Niya
    Saleesee, Nareumon
    Intasang, Marisa
    Sanit, Jantira
    Adulyaritthikul, Punyanuch
    Kongpol, Kantapich
    Kumphune, Sarawut
    Nernpermpisooth, Nitirut
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (02) : 228 - 234
12345